[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"dermatophyte-infection\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:dermatophyte-infection":23},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,36],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":25,"lastUpdatePostDateStruct":26,"startDateStruct":29,"completionDateStruct":31,"leadSponsor":33,"locationsCount":4},"100572126","fungal-resistance-in-dermatophyte-infection-100572126",false,"NCT06729216","Fungal Resistance in Dermatophyte Infection","Species Identification and Antifungal Susceptibility Testing of Dermatophytes Isolated From Patients Attending Dermatology Outpatient Clinic at Kasr Alainy Hospitals","Inclusion Criteria:\n\n* Patients diagnosed clinically with dermatophytosis, any age group and any sex\n\nExclusion Criteria:\n\n* Patients under either Local or systemic antifungal treatment","ALL",{"count":18,"type":19},42,"ESTIMATED","OBSERVATIONAL","The aim of the study is to compare the efficiency of broth microdilution versus disk diffusion method for antifungal drug susceptibility testing of the most used drugs in dermatophytosis treatment.",[23],"Dermatophyte Infection","NOT_YET_RECRUITING","2025-05-10",{"date":27,"type":28},"2025-05-14","ACTUAL",{"date":30,"type":19},"2025-06-01",{"date":32,"type":19},"2025-08-01",{"name":34,"class":35},"Cairo University","OTHER",{"id":37,"slug":38,"hasResults":11,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":4,"eligibilityCriteria":42,"healthyVolunteers":11,"sex":16,"minAge":43,"maxAge":44,"enrollmentInfo":45,"targetDuration":4,"studyType":47,"phases":48,"briefSummary":50,"conditions":51,"keywords":52,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":67},"100568386","phase-2-role-of-oral-voriconazole-in-the-treatment-of-resistant-dermatophyte-infections-100568386","NCT06680544","Role of Oral Voriconazole in the Treatment of Resistant Dermatophyte Infections","Comparing the Efficacy of Oral 200 Milligram Voriconazole Once a Day Vs. Twice a Day in the Treatment of Resisitant Dermatophyte Infections (Tinea Corporis and Tinea Cruris)","Inclusion Criteria:\n\n1. Resistant cases of tinea cruris and tinea corporis: Those cases who received the standard dosage of oral antifungals i.e. oral terbinafine 5mg\u002Fkg per day for 4 weeks or oral itraconazole 5mg per\u002Fkg\u002Fday for 4 weeks but they did not recover from the infection.\n2. Skin area: Groin and trunk\n3. Total diameter of the lesions: 5cm to 80 cm\n\nExclusion Criteria:\n\n1. History of hypersensitivity to azoles\n2. All those individuals having immunocompromised state (malignancy, tuberculosis, AIDS, history of organ transplant and history of immunosuppressive drug treatment etc.)\n3. Patients of diabetes, liver or kidney disease.\n4. Lactating mother\n5. Pregnant female","18 Years","60 Years",{"count":46,"type":19},120,"INTERVENTIONAL",[49],"PHASE2","Treatment of dermatophyte infection in our country (Pakistan) is becoming difficult due to the developing resistance to traditional antifungal agents. Assessing the effectiveness ,feasibility and standard dosage of a newer antifungal drug like voriconazole is the need of the hour in resistant cases of dermatophyte infection.",[23],[53,54,55,56],"Tinea","Voriconazole","Dermatomycoses","Antifungal Agents","2024-11-07",{"date":59,"type":28},"2024-11-08",{"date":61,"type":19},"2024-11-15",{"date":63,"type":19},"2025-03-15",{"name":65,"class":66},"Sheikh Zayed Medical College","OTHER_GOV",1]